Provided by Tiger Trade Technology Pte. Ltd.

Biogen

222.82
-3.0600-1.35%
Pre-market: 223.530.7100+0.32%08:34 EDT
Volume:1.76M
Turnover:394.33M
Market Cap:32.90B
PE:39.58
High:228.31
Open:225.50
Low:222.50
Close:225.88
52wk High:230.49
52wk Low:138.00
Shares:147.64M
Float Shares:147.31M
Volume Ratio:1.45
T/O Rate:1.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.63
EPS(LYR):8.79
ROE:4.58%
ROA:5.21%
PB:1.75
PE(LYR):25.35

Loading ...

Biogen Outlook Expected Dilution from Apellis Deal on FY Adj EPS $-0.85

THOMSON REUTERS
·
Jul 29

Biogen price target raised to $200 from $185 at Barclays

TIPRANKS
·
Jul 29

Biogen beats estimates as new medicines overtake multiple sclerosis business

Robert Langreth / Bloomberg
·
Jul 29

U.S. Research ROUNDUP-Boeing, Coca-Cola, PayPal

Reuters
·
Jul 29

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 29

Barclays Adjusts Biogen Price Target to $200 From $185, Maintains Equalweight Rating

MT Newswires Live
·
Jul 28

Biogen Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 28

Biogen’s BIIB144 First‑in‑Human Trial: What Early Safety Data Could Mean for BIIB Investors

TIPRANKS
·
Jul 28

Rothschild & Co Redburn Adjusts Price Target on Biogen to $210 From $190, Maintains Neutral Rating

MT Newswires Live
·
Jul 24

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 24

Earning Preview: Biogen Q2 revenue is expected to increase by 5.80%, majority of institutions hold constructive views

Earnings Agent
·
Jul 22

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 22

Biogen: Balanced Risk-Reward Keeps Rating at Hold Amid MS Pressure and Uncertain New Asset Contributions

TIPRANKS
·
Jul 22

Biogen is Maintained at Neutral by B of a Securities

Dow Jones
·
Jul 21

U.S. Research Roundup-colgate-palmolive, IBM, Unitedhealth

Reuters
·
Jul 21

Biogen (BIIB) Expands Its Alzheimer’s Pipeline, Is The 9% Undervaluation Still There?

Simply Wall St.
·
Jul 21

Biogen Inc. Stock Falls 2.9%, Underperforms Peers

Dow Jones
·
Jul 21

Goldman Sachs Adjusts Price Target on Biogen to $271 From $250, Maintains Buy Rating

MT Newswires Live
·
Jul 20

Biogen, Bloom, First Solar, Oklo, NNE Trending With Analysts

TIPRANKS
·
Jul 18

Biogen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Jul 18